Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting mTOR and NGFR Pathways. (2026). Science Essence Journal, 42(1), 50-70. https://doi.org/10.69523/sej.2026.42.17130